MAP3K7 and prostate carcinoma: CHD1 depletion reduced cell proliferation, invasiveness, and tumor growth of PTEN-deficient cancer cells (14, 20, 25, 26); while loss of MAP3K7 and CHD1 coordinates to promote aggressive prostate cancer (20, 61).